Bacterial Antigen Ingredients TRIZ Cases

Conserved TSA56 epitopes enable a single vaccine to protect against diverse scrub typhus genotypes, overcoming cross-genotype limitations.

Surface-displayed fusion proteins on probiotic-derived vesicles induce antigen-specific TH1-biased immunity while maintaining vaccine safety.

Engineered gut bacteria deliver vaccine antigens via outer membrane vesicles to mucosal sites.

Circularly polarized light imparts nanoscale chirality to gold nanoparticles, enabling enantiomer-dependent binding affinity to immune cell receptors.

Segmented glycoconjugates merge multiple serotypes into one formulation to overcome insufficient protection coverage in current vaccines.

A probiotic composition comprising Bifidobacterium breve and non-digestible oligosaccharides enhances peak expiratory flow rate.

Conjugating Campylobacter jejuni capsule polysaccharides to carrier proteins avoids autoimmune induction while enhancing immune response efficacy.

Chimeric polypeptides bypass TAP deficiency by delivering signal peptides to cancer cells, enabling HLA binding and converting cold tumors into hot targets.

Engineered Corynebacterium diphtheriae strain overcomes low yield bottlenecks by increasing tox gene copies and using amino acid-rich media.

Vaccine compositions combine conjugate antigens with mucosal adjuvants to block transmission and reduce invasive disease incidence.

A mutated Bordetella pertussis strain induces protective immunity against allergic diseases.

Introducing M. marinum ESX-1 genes into BCG raises protective immune response while keeping virulence low.

Inactivated mycobacterial components stimulate immune cell invasion into tumors while eliminating the severe side effects of live bacterial therapies.

Conjugating purified capsular polysaccharides to carrier proteins resolves infant immune unresponsiveness while expanding serotype coverage.

ISG15 adjuvant increases IFN-gamma, TNF-alpha, and IL-2 production to overcome weak antigen immunogenicity.

Segmented computational modules identify conserved epitopes to reduce selective pressure risk.

Truncated TpN47 antigens lacking domain C prevent thermal aggregation, ensuring reliable antibody detection in syphilis immunoassays.

Standardized aqueous-ethanol extraction resolves conflicting antimicrobial results while treating Klebsiella pneumoniae infections.

Lactobacillus paracasei K56 withstands gastrointestinal stress to regulate flora balance without antibiotic resistance risks.

Bacterial membrane nanoparticles capture cancer antigens and deliver immune adjuvants to stimulate innate and adaptive responses in cold tumor models.

Novel Parabacteroides goldsteinii strain MTS01 prevents weight gain and treats obesity through gut microbiota modulation.

Nanoemulsion formulation stabilizes Hepatitis B surface antigen across temperatures, eliminating cold chain requirements.

Incorporating glycolipids into cationic liposomal bilayers prevents aggregation and precipitation during storage, maintaining adjuvant efficacy.

Bacteriophages infect and lyse vancomycin-resistant enterococci, avoiding antibiotic resistance side effects.

Targeted injection of botulinum neurotoxin into defined muscle groups reduces tremor severity while minimizing adverse effects like muscle weakness.

Gene knockout mutations remove virulence factors from Brucella canis, reducing side effects while maintaining protective immunity.

Amorphous silica encapsulation prevents thermal denaturation and unfolding, enabling stable room temperature storage without refrigeration.

Patsnap Eureka TRIZ case: Isolated bacterial amyloid peptides activate the TLR2/PI3K pathway to reduce epithelial permeability and side effects.

Switching from 30 kDa to 10 kDa membranes eliminates steric hindrance and chromatography steps, raising type II GBS yield to 90%.

Segmented detection of vaccine-specific and infection-specific polypeptides resolves the inability to differentiate natural infections from vaccination status.

Isolated Mycobacterium vaccae induces an anti-inflammatory immunophenotype in the hippocampus to mitigate cognitive dysfunction.

Targeted gene mutations create attenuated strains that reduce rickettsemia and clear pathogens.

Antigenic compositions induce protective immunity against heterologous pathogens via pattern recognition receptors.

Targeted phtcp gene deletion creates attenuated Anaplasma marginale strains that reduce clinical disease severity and pathogen transmissibility in cattle.

A diagnostic kit employs mycolic-acid derived antigens to detect biomarker binding in patient samples.

Composite MAP antigen panels improve diagnostic reliability by detecting subclinical infections without increasing assay complexity.

SlpA-expressing probiotics occupy intestinal epithelial cells to prevent Clostridium difficile colonization without altering the microbiome.

Genetic engineering of Wzz proteins controls O-polysaccharide chain length, resolving the trade-off between immunogenicity and production cost.

A multivalent vaccine formulation combines multiple Leptospira serovars to induce protective immunity in canines.

Novel shuttle vector with oriM origin and specific promoters resolves incorrect protein folding issues while maintaining dual-host replication capability.

Recombinant Y. pseudotuberculosis vectors provide broad protection against plague and Yersiniosis by expressing multiple antigens simultaneously.

Modifies dimethyl fumarate dosage during vaccination to prevent immune suppression and adverse effects while maintaining therapeutic efficacy.

Site-directed mutations in the BoNT/B4 heavy chain increase human SytII binding affinity, reducing required toxin doses and minimizing adverse immune responses.

Auxotrophic Mycobacterium strain with deleted argB and metA genes elicits protective immune responses while avoiding persistence in human challenge trials.

A bifunctional conjugate links tumor-binding peptides to pathogen-recognition ligands.

GlXmGn nucleic acid molecules elicit unspecific immune responses while minimizing skin irritation and cancer risks from genomic integration.

Multi-component inactivated Bizionia vaccine reduces winter ulcer mortality and meat quality loss.